There is significant interest in targeting Notch1 signaling for the treatment of a number of cancers but previous studies have shown chronic Notch inhibition can lead to detrimental secondary effects and in some cases increased vascular tumor development21, 58. The gene discussed is NOTCH1; the disease is vascular neoplasm.